Eric Dobmeier - Director at Atara Biotherapeutics, Inc.

Insider Transactions and Holdings

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	563K	$219K	$0.39	Nov 10, 2023	Direct
Non-Qualified Stock Option (Right to Buy)	79.5K			May 31, 2023	Direct	Common Stock

Showing 1 to 2 of 2 entries

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.